Tracheostomy Products Market Size (2024 - 2029)

Tracheostomy Products Market Analysis

Over the next few years, the market for tracheostomy products is expected to grow at a CAGR of 6.2%.

The pandemic impacted the market for tracheostomy products. Many surgical interventions, including cardiovascular surgeries, were postponed or canceled during the pandemic, which reduced the demand for tracheostomy products. For instance, according to the WHO report published in June 2021, since the COVID-19 pandemic started, prevention and treatment services for noncommunicable diseases (NCDs) have been badly interrupted. The survey was completed by 155 countries over three weeks in May. The same source also reported that 31.0% of the countries had partially or entirely disrupted services for cardiovascular emergencies. Thus, owing to the reduction of surgical interventions during the pandemic, the demand for tracheostomy products slightly decreased, thereby creating a slight negative impact on the market during the initial days of the pandemic. However, as the COVID-19 cases declined, surgical procedures associated with various diseases started to resume. For instance, in April 2021, the world's first human tracheal transplant was carried out by a group of Mount Sinai surgeons in New York. Therefore, with the positive developments in the later times of the pandemic, the market started to gain momentum and is expected to maintain an upward trend over the forecast period.

The increasing prevalence of respiratory and other chronic disorders, technological advancements, favorable reimbursement scenarios, and favorable reimbursement scenarios are the major factors driving market growth. In addition, technological advancements and favorable reimbursement scenarios are also positively impacting market growth. The major factor attributing to the growth of the market is the increase in the prevalence of respiratory diseases, such as asthma, exercise-induced bronchospasm, emphysema, allergic rhinitis, primary dysmenorrhea, pneumonia, and lung cancer. For instance, according to the Global Initiative for Chronic Obstructive Lung Disease 2021 report, the prevalence of COPD was higher in smokers as compared to nonsmokers, and most of the national data suggested that COPD was diagnosed in approximately 6.0% of the adult population across the globe. Furthermore, according to the WHO 2022 update, more than 262.0 million people suffered from asthma in 2021. The tracheostomy products provide an air passage that helps in breathing when the usual route for breathing is blocked or reduced. It is highly recommended for patients suffering from asthma and other respiratory diseases. Therefore, increasing cases of respiratory diseases are anticipated to propel the demand for tracheostomy products, thereby propelling market growth.

Furthermore, tracheostomies are most often used when treating patients with head and neck cancers, including tongue cancer, oral cancer, and thyroid cancer. For instance, according to the World Cancer Research Fund International 2022 report, there were more than 2.2 million new cases of lung cancer in 2021. Cancers of the lip, oral cavity, hypopharynx, oropharynx, and larynx are collectively known as mouth and oral cancers. The same source also reported that the most prevalent of them are cancers of the lip and oral cavity, with more than 377,700 new cases worldwide in 2021. Therefore, the high prevalence of oral and lung cancer is anticipated to augment market growth over the forecast period.

However, the high cost of tracheostomy procedures and the risk of infection during procedures are likely to impede market growth over the forecast period.

Tracheostomy Products Industry Segmentation

According to the scope of the report, tracheostomy is the process of creating an opening in the neck and windpipe to allow for unrestricted breathing. There is a wide range of tracheostomy products available, each with its own set of features designed for a specific purpose. Tracheostomy is considered one of the most frequently performed surgical procedures in intensive care units. The tracheostomy products market is segmented by product type (tracheostomy tubes, tracheostomy ventilation accessories, tracheostomy cleaning kits, and other accessories), material (polyvinyl chloride and polyurethane, silicone, and other materials), end user (hospitals, ambulatory care centers, and other end users), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.